iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
19 09 2019
Historique:
received: 31 08 2018
accepted: 08 08 2019
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 2 10 2020
Statut: epublish

Résumé

The control of voluntary skeletal muscle contraction relies on action potentials, which send signals from the motor neuron through the neuromuscular junction (NMJ). Although dysfunction of the NMJ causes various neuromuscular diseases, a reliable in vitro system for disease modeling is currently unavailable. Here, we present a potentially novel 2-step, self-organizing approach for generating in vitro human NMJs from human induced pluripotent stem cells. Our simple and robust approach results in a complex NMJ structure that includes functional connectivity, recapitulating in vivo synapse formation. We used these in vitro NMJs to model the pathological features of spinal muscular atrophy, revealing the developmental and functional defects of NMJ formation and NMJ-dependent muscular contraction. Our differentiation system is therefore useful for investigating and understanding the physiology and pathology of human NMJs.

Identifiants

pubmed: 31534050
pii: 124299
doi: 10.1172/jci.insight.124299
pmc: PMC6795289
doi:
pii:

Substances chimiques

SMN1 protein, human 0
Survival of Motor Neuron 1 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Physiol. 1975 Sep;251(1):131-44
pubmed: 1185611
JAMA Neurol. 2015 Jun;72(6):666-75
pubmed: 25844556
News Physiol Sci. 2004 Jun;19:85-91
pubmed: 15143199
Stem Cell Reports. 2015 Apr 14;4(4):561-8
pubmed: 25801509
Neuron. 2003 Jan 9;37(1):67-73
pubmed: 12526773
Science. 1997 Jan 17;275(5298):356-61
pubmed: 8994026
PLoS One. 2012;7(5):e36049
pubmed: 22574134
Nat Methods. 2006 Oct;3(10):785-92
pubmed: 16990810
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4359-64
pubmed: 15749817
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Biomaterials. 2011 Dec;32(36):9602-11
pubmed: 21944471
Int J Mol Sci. 2017 Oct 19;18(10):null
pubmed: 29048368
Development. 2016 Jul 1;143(13):2464-77
pubmed: 27226316
Hum Mol Genet. 2008 Aug 15;17(16):2552-69
pubmed: 18492800
Mech Dev. 2013 Jun-Aug;130(6-8):402-11
pubmed: 23032192
Cell Stem Cell. 2016 Jul 7;19(1):95-106
pubmed: 27320040
Cell Mol Life Sci. 2015 Aug;72(15):2929-35
pubmed: 26084874
Cell Tissue Res. 2006 Nov;326(2):263-71
pubmed: 16819627
Annu Rev Neurosci. 1999;22:389-442
pubmed: 10202544
Curr Opin Neurol. 2014 Oct;27(5):566-75
pubmed: 25159927
Front Cell Neurosci. 2015 Dec 08;9:473
pubmed: 26696831
Curr Neurol Neurosci Rep. 2010 Mar;10(2):108-17
pubmed: 20425235
J Cell Sci. 2005 Jan 1;118(Pt 1):27-37
pubmed: 15601660
J Neurosci. 1993 Feb;13(2):834-55
pubmed: 8426240
Tissue Eng Part C Methods. 2012 Jan;18(1):21-32
pubmed: 21851323
Nature. 1986 May 22-28;321(6068):406-11
pubmed: 2423878
Nature. 2011 Feb 17;470(7334):394-8
pubmed: 21331042
Cell Stem Cell. 2016 Jan 7;18(1):134-43
pubmed: 26549107
J Neurosci. 2000 May 15;20(10):3663-75
pubmed: 10804208
Neuron. 2000 Feb;25(2):269-78
pubmed: 10719884
Histochem Cell Biol. 2006 Jun;125(6):705-16
pubmed: 16341870
PLoS One. 2013 Apr 23;8(4):e61540
pubmed: 23626698
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
PLoS One. 2013 Aug 15;8(8):e71965
pubmed: 23967270
J Neuropathol Exp Neurol. 1977 Mar-Apr;36(2):245-75
pubmed: 839240
Front Cell Neurosci. 2011 Dec 12;5:26
pubmed: 22180738
J Anat. 2012 Feb;220(2):122-30
pubmed: 22133357
Stem Cell Res Ther. 2014 Jul 14;5(4):87
pubmed: 25157556
Cell Rep. 2017 Nov 28;21(9):2348-2356
pubmed: 29186674
Stem Cell Res. 2015 Sep;15(2):328-36
pubmed: 26255853
Dev Neurobiol. 2014 Aug;74(8):828-38
pubmed: 24838312
Cell Res. 2013 Mar;23(3):378-93
pubmed: 23208423
Science. 2002 Oct 25;298(5594):770-6
pubmed: 12399577
PLoS Biol. 2012;10(6):e1001352
pubmed: 22745601
Hum Mol Genet. 2012 Jan 1;21(1):185-95
pubmed: 21968514

Auteurs

Chuang-Yu Lin (CY)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Michiko Yoshida (M)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Li-Tzu Li (LT)

Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei, Taiwan.

Akihiro Ikenaka (A)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Shiori Oshima (S)

Sony Imaging Products & Solutions Inc., Tokyo, Japan.

Kazuhiro Nakagawa (K)

Sony Imaging Products & Solutions Inc., Tokyo, Japan.

Hidetoshi Sakurai (H)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Eriko Matsui (E)

Sony Imaging Products & Solutions Inc., Tokyo, Japan.

Tatsutoshi Nakahata (T)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Megumu K Saito (MK)

Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH